vs
Side-by-side financial comparison of Lovesac Co (LOVE) and Stoke Therapeutics, Inc. (STOK). Click either name above to swap in a different company.
Stoke Therapeutics, Inc. is the larger business by last-quarter revenue ($158.6M vs $150.2M, roughly 1.1× Lovesac Co). Stoke Therapeutics, Inc. runs the higher net margin — 71.2% vs -7.0%, a 78.2% gap on every dollar of revenue. On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs 0.2%). Stoke Therapeutics, Inc. produced more free cash flow last quarter ($131.7M vs $-10.2M).
The Lovesac Company is an American furniture retailer, specializing in a patented modular furniture system called Sactionals. Sactionals consist of two combinable pieces, “Seats” and “Sides,” as well as custom-fit covers and associated accessories. Lovesac also sells Sacs, a bag seat filled with a proprietary foam mixture.
Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.
LOVE vs STOK — Head-to-Head
Income Statement — Q3 FY2026 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $150.2M | $158.6M |
| Net Profit | $-10.6M | $112.9M |
| Gross Margin | 56.1% | — |
| Operating Margin | -10.5% | 70.2% |
| Net Margin | -7.0% | 71.2% |
| Revenue YoY | 0.2% | 3661.1% |
| Net Profit YoY | -114.0% | 528.0% |
| EPS (diluted) | $-0.72 | $1.90 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $150.2M | — | ||
| Q3 25 | $160.5M | — | ||
| Q2 25 | $138.4M | — | ||
| Q1 25 | $241.5M | $158.6M | ||
| Q4 24 | $149.9M | $22.6M | ||
| Q3 24 | $156.6M | — | ||
| Q2 24 | $132.6M | — | ||
| Q1 24 | $250.5M | — |
| Q4 25 | $-10.6M | — | ||
| Q3 25 | $-6.7M | — | ||
| Q2 25 | $-10.8M | — | ||
| Q1 25 | $35.3M | $112.9M | ||
| Q4 24 | $-4.9M | $-10.5M | ||
| Q3 24 | $-5.9M | — | ||
| Q2 24 | $-13.0M | — | ||
| Q1 24 | $31.0M | — |
| Q4 25 | 56.1% | — | ||
| Q3 25 | 56.4% | — | ||
| Q2 25 | 53.7% | — | ||
| Q1 25 | 60.4% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 59.0% | — | ||
| Q2 24 | 54.3% | — | ||
| Q1 24 | 59.7% | — |
| Q4 25 | -10.5% | — | ||
| Q3 25 | -5.5% | — | ||
| Q2 25 | -10.8% | — | ||
| Q1 25 | 19.7% | 70.2% | ||
| Q4 24 | -5.2% | -60.4% | ||
| Q3 24 | -5.3% | — | ||
| Q2 24 | -13.5% | — | ||
| Q1 24 | 16.1% | — |
| Q4 25 | -7.0% | — | ||
| Q3 25 | -4.1% | — | ||
| Q2 25 | -7.8% | — | ||
| Q1 25 | 14.6% | 71.2% | ||
| Q4 24 | -3.3% | -46.4% | ||
| Q3 24 | -3.7% | — | ||
| Q2 24 | -9.8% | — | ||
| Q1 24 | 12.4% | — |
| Q4 25 | $-0.72 | — | ||
| Q3 25 | $-0.45 | — | ||
| Q2 25 | $-0.73 | — | ||
| Q1 25 | $2.22 | $1.90 | ||
| Q4 24 | $-0.32 | $-0.15 | ||
| Q3 24 | $-0.38 | — | ||
| Q2 24 | $-0.83 | — | ||
| Q1 24 | $1.91 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $23.7M | $274.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $189.3M | $350.1M |
| Total Assets | $495.5M | $406.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $23.7M | — | ||
| Q3 25 | $34.2M | — | ||
| Q2 25 | $26.9M | — | ||
| Q1 25 | $83.7M | $274.8M | ||
| Q4 24 | $61.7M | $128.0M | ||
| Q3 24 | $72.1M | — | ||
| Q2 24 | $72.4M | — | ||
| Q1 24 | $87.0M | — |
| Q4 25 | $189.3M | — | ||
| Q3 25 | $197.5M | — | ||
| Q2 25 | $201.2M | — | ||
| Q1 25 | $216.4M | $350.1M | ||
| Q4 24 | $196.5M | $229.0M | ||
| Q3 24 | $202.1M | — | ||
| Q2 24 | $205.3M | — | ||
| Q1 24 | $217.5M | — |
| Q4 25 | $495.5M | — | ||
| Q3 25 | $493.7M | — | ||
| Q2 25 | $483.7M | — | ||
| Q1 25 | $532.3M | $406.9M | ||
| Q4 24 | $499.7M | $271.6M | ||
| Q3 24 | $481.1M | — | ||
| Q2 24 | $477.2M | — | ||
| Q1 24 | $482.2M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-4.9M | $131.8M |
| Free Cash FlowOCF − Capex | $-10.2M | $131.7M |
| FCF MarginFCF / Revenue | -6.8% | 83.0% |
| Capex IntensityCapex / Revenue | 3.5% | 0.1% |
| Cash ConversionOCF / Net Profit | — | 1.17× |
| TTM Free Cash FlowTrailing 4 quarters | $-13.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-4.9M | — | ||
| Q3 25 | $12.2M | — | ||
| Q2 25 | $-41.4M | — | ||
| Q1 25 | $44.0M | $131.8M | ||
| Q4 24 | $-4.2M | $-23.2M | ||
| Q3 24 | $6.2M | — | ||
| Q2 24 | $-7.0M | — | ||
| Q1 24 | $56.3M | — |
| Q4 25 | $-10.2M | — | ||
| Q3 25 | $7.8M | — | ||
| Q2 25 | $-50.0M | — | ||
| Q1 25 | $38.7M | $131.7M | ||
| Q4 24 | $-6.6M | $-23.2M | ||
| Q3 24 | $119.0K | — | ||
| Q2 24 | $-14.3M | — | ||
| Q1 24 | $49.5M | — |
| Q4 25 | -6.8% | — | ||
| Q3 25 | 4.9% | — | ||
| Q2 25 | -36.1% | — | ||
| Q1 25 | 16.0% | 83.0% | ||
| Q4 24 | -4.4% | -102.7% | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | -10.8% | — | ||
| Q1 24 | 19.8% | — |
| Q4 25 | 3.5% | — | ||
| Q3 25 | 2.7% | — | ||
| Q2 25 | 6.2% | — | ||
| Q1 25 | 2.2% | 0.1% | ||
| Q4 24 | 1.6% | 0.2% | ||
| Q3 24 | 3.9% | — | ||
| Q2 24 | 5.5% | — | ||
| Q1 24 | 2.7% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.25× | 1.17× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 1.82× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LOVE
| Showrooms | $102.7M | 68% |
| Internet | $37.3M | 25% |
| Other | $10.2M | 7% |
STOK
Segment breakdown not available.
